• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在资源有限的环境中开发一种用于诊断 HIV 相关痴呆症的可行诊断工具的经验教训:肯尼亚的试点测试。

Lessons learned developing a diagnostic tool for HIV-associated dementia feasible to implement in resource-limited settings: pilot testing in Kenya.

机构信息

Center for Microbiology Research Kenya Medical Research Institute, Nairobi, Kenya.

出版信息

PLoS One. 2012;7(3):e32898. doi: 10.1371/journal.pone.0032898. Epub 2012 Mar 7.

DOI:10.1371/journal.pone.0032898
PMID:22412945
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3296754/
Abstract

OBJECTIVE

To conduct a preliminary evaluation of the utility and reliability of a diagnostic tool for HIV-associated dementia (HAD) for use by primary health care workers (HCW) which would be feasible to implement in resource-limited settings.

BACKGROUND

In resource-limited settings, HAD is an indication for anti-retroviral therapy regardless of CD4 T-cell count. Anti-retroviral therapy, the treatment for HAD, is now increasingly available in resource-limited settings. Nonetheless, HAD remains under-diagnosed likely because of limited clinical expertise and availability of diagnostic tests. Thus, a simple diagnostic tool which is practical to implement in resource-limited settings is an urgent need.

METHODS

A convenience sample of 30 HIV-infected outpatients was enrolled in Western Kenya. We assessed the sensitivity and specificity of a diagnostic tool for HAD as administered by a primary HCW. This was compared to an expert clinical assessment which included examination by a physician, neuropsychological testing, and in selected cases, brain imaging. Agreement between HCW and an expert examiner on certain tool components was measured using Kappa statistic.

RESULTS

The sample was 57% male, mean age was 38.6 years, mean CD4 T-cell count was 323 cells/µL, and 54% had less than a secondary school education. Six (20%) of the subjects were diagnosed with HAD by expert clinical assessment. The diagnostic tool was 63% sensitive and 67% specific for HAD. Agreement between HCW and expert examiners was poor for many individual items of the diagnostic tool (K = .03-.65). This diagnostic tool had moderate sensitivity and specificity for HAD. However, reliability was poor, suggesting that substantial training and formal evaluations of training adequacy will be critical to enable HCW to reliably administer a brief diagnostic tool for HAD.

摘要

目的

初步评估一种适用于基层卫生保健工作者(HCW)且在资源有限环境中易于实施的用于诊断 HIV 相关痴呆(HAD)的诊断工具的实用性和可靠性。

背景

在资源有限的环境中,无论 CD4 T 细胞计数如何,HAD 都是开始抗逆转录病毒治疗的指征。抗逆转录病毒治疗是 HAD 的治疗方法,现在在资源有限的环境中越来越普及。尽管如此,由于临床专业知识有限且缺乏诊断测试,HAD 的诊断仍然不足。因此,迫切需要一种简单的诊断工具,该工具在资源有限的环境中切实可行。

方法

在肯尼亚西部,我们方便地招募了 30 名 HIV 感染门诊患者。我们评估了由基层 HCW 实施的 HAD 诊断工具的灵敏度和特异性。将其与专家临床评估进行比较,后者包括医生检查、神经心理测试,以及在某些情况下进行脑部成像。使用 Kappa 统计量来衡量 HCW 和专家检查者在某些工具组件上的一致性。

结果

该样本中 57%为男性,平均年龄为 38.6 岁,平均 CD4 T 细胞计数为 323 个/µL,54%的人受教育程度低于中学。通过专家临床评估,有 6 名(20%)患者被诊断为 HAD。该诊断工具对 HAD 的灵敏度为 63%,特异性为 67%。HCW 和专家检查者之间对诊断工具的许多单个项目的一致性较差(K 值为.03-.65)。该诊断工具对 HAD 具有中等的灵敏度和特异性。然而,可靠性较差,这表明 HCW 要能够可靠地管理 HAD 的简短诊断工具,需要进行大量培训和正式评估培训的充分性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5ab/3296754/e5d1a2e6bb17/pone.0032898.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5ab/3296754/e5d1a2e6bb17/pone.0032898.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5ab/3296754/e5d1a2e6bb17/pone.0032898.g001.jpg

相似文献

1
Lessons learned developing a diagnostic tool for HIV-associated dementia feasible to implement in resource-limited settings: pilot testing in Kenya.在资源有限的环境中开发一种用于诊断 HIV 相关痴呆症的可行诊断工具的经验教训:肯尼亚的试点测试。
PLoS One. 2012;7(3):e32898. doi: 10.1371/journal.pone.0032898. Epub 2012 Mar 7.
2
Utility of quantitative sensory testing and screening tools in identifying HIV-associated peripheral neuropathy in Western Kenya: pilot testing.在肯尼亚西部,定量感觉测试和筛查工具在识别 HIV 相关周围神经病变中的效用:初步测试。
PLoS One. 2010 Dec 8;5(12):e14256. doi: 10.1371/journal.pone.0014256.
3
Limitations of the International HIV Dementia Scale in the current era.国际艾滋病痴呆量表在当前时代的局限性。
AIDS. 2018 Nov 13;32(17):2477-2483. doi: 10.1097/QAD.0000000000001968.
4
Training needs and evaluation of a neuro-HIV training module for non-physician healthcare workers in western Kenya.在肯尼亚西部,针对非医师的医疗卫生工作者的神经艾滋病培训模块的培训需求和评估。
J Neurol Sci. 2011 Aug 15;307(1-2):92-6. doi: 10.1016/j.jns.2011.05.005. Epub 2011 Jun 11.
5
A brief and feasible paper-based method to screen for neurocognitive impairment in HIV-infected patients: the NEU screen.一种用于筛选 HIV 感染患者神经认知障碍的简便可行的基于纸的方法:NEU 筛选。
J Acquir Immune Defic Syndr. 2013 Aug 15;63(5):585-92. doi: 10.1097/QAI.0b013e31829e1408.
6
Simulated patient encounters to improve adolescent retention in HIV care in Kenya: study protocol of a stepped-wedge randomized controlled trial.模拟患者诊疗以提高肯尼亚青少年对艾滋病护理的依从性:一项阶梯式楔形随机对照试验的研究方案
Trials. 2017 Dec 28;18(1):619. doi: 10.1186/s13063-017-2266-z.
7
Screening for HIV-associated peripheral neuropathy in resource-limited settings.在资源有限的环境中筛查 HIV 相关周围神经病变。
Muscle Nerve. 2013 Oct;48(4):516-24. doi: 10.1002/mus.23795. Epub 2013 Aug 27.
8
Screening for HIV-associated neurocognitive disorders in perinatally infected adolescents: youth-International HIV Dementia Scale validation.筛查围生期感染青少年中的 HIV 相关神经认知障碍:青少年-国际 HIV 痴呆量表的验证。
AIDS. 2019 Apr 1;33(5):815-824. doi: 10.1097/QAD.0000000000002144.
9
Validation of the International HIV Dementia Scale as a Screening Tool for HIV-Associated Neurocognitive Disorders in a German-Speaking HIV Outpatient Clinic.国际艾滋病痴呆量表作为德语区艾滋病门诊中与艾滋病相关神经认知障碍筛查工具的验证
PLoS One. 2016 Dec 19;11(12):e0168225. doi: 10.1371/journal.pone.0168225. eCollection 2016.
10
Misclassification of first-line antiretroviral treatment failure based on immunological monitoring of HIV infection in resource-limited settings.在资源有限的环境中,基于对HIV感染的免疫监测对一线抗逆转录病毒治疗失败的错误分类。
Clin Infect Dis. 2009 Aug 1;49(3):454-62. doi: 10.1086/600396.

引用本文的文献

1
Epidemiology of neurodegenerative diseases in the East African region: A meta-analysis.东非地区神经退行性疾病的流行病学:一项荟萃分析。
Front Neurol. 2022 Nov 17;13:1024004. doi: 10.3389/fneur.2022.1024004. eCollection 2022.
2
The global burden of cognitive impairment in people with HIV.全球艾滋病毒感染者认知障碍负担。
AIDS. 2023 Jan 1;37(1):61-70. doi: 10.1097/QAD.0000000000003379. Epub 2022 Sep 15.
3
HIV-associated neurocognitive disorders at Moi teaching and referral hospital, Eldoret, Kenya.HIV 相关神经认知障碍于肯尼亚埃尔多雷特莫伊教学与转诊医院。

本文引用的文献

1
Normative scores for a brief neuropsychological battery for the detection of HIV-associated neurocognitive disorder (HAND) among South Africans.用于在南非人群中检测与艾滋病相关神经认知障碍(HAND)的简短神经心理学成套测验的常模分数。
BMC Res Notes. 2010 Jan 29;3:28. doi: 10.1186/1756-0500-3-28.
2
Closing gaps in antiretroviral therapy access: human immunodeficiency virus-associated dementia screening instruments for non-physician healthcare workers.缩小抗逆转录病毒治疗可及性方面的差距:供非医师医护人员使用的人类免疫缺陷病毒相关痴呆筛查工具
Am J Trop Med Hyg. 2009 Jun;80(6):1054-9.
3
Antiretroviral adherence in rural Zambia: the first year of treatment availability.
BMC Neurol. 2020 Jul 14;20(1):280. doi: 10.1186/s12883-020-01857-3.
4
Utility of the International HIV Dementia Scale for HIV-Associated Neurocognitive Disorder.国际HIV痴呆量表在HIV相关神经认知障碍中的应用
J Acquir Immune Defic Syndr. 2020 Mar 1;83(3):278-283. doi: 10.1097/QAI.0000000000002257.
5
The Veterans Aging Cohort Study Index is not associated with HIV-associated neurocognitive disorders in Uganda.乌干达退伍军人老龄化队列研究指数与HIV相关神经认知障碍无关。
J Neurovirol. 2020 Apr;26(2):252-256. doi: 10.1007/s13365-019-00806-2. Epub 2019 Nov 12.
6
Limitations of the International HIV Dementia Scale in the current era.国际艾滋病痴呆量表在当前时代的局限性。
AIDS. 2018 Nov 13;32(17):2477-2483. doi: 10.1097/QAD.0000000000001968.
7
Changing clinical phenotypes of HIV-associated neurocognitive disorders.HIV 相关神经认知障碍的临床表型改变。
J Neurovirol. 2018 Apr;24(2):141-145. doi: 10.1007/s13365-017-0556-6. Epub 2017 Jul 27.
8
Validation of the International HIV Dementia Scale as a Screening Tool for HIV-Associated Neurocognitive Disorders in a German-Speaking HIV Outpatient Clinic.国际艾滋病痴呆量表作为德语区艾滋病门诊中与艾滋病相关神经认知障碍筛查工具的验证
PLoS One. 2016 Dec 19;11(12):e0168225. doi: 10.1371/journal.pone.0168225. eCollection 2016.
9
Relationship between HIV stage and psychomotor speed neurocognitive score at a Kenyan sub-county hospital.肯尼亚某县级医院中HIV分期与精神运动速度神经认知评分之间的关系。
Afr J Prim Health Care Fam Med. 2016 Aug 31;8(1):e1-8. doi: 10.4102/phcfm.v8i1.1061.
10
HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment.人类免疫缺陷病毒相关神经认知障碍——发病机制与治疗前景
Nat Rev Neurol. 2016 Apr;12(4):234-48. doi: 10.1038/nrneurol.2016.27. Epub 2016 Mar 11.
赞比亚农村地区的抗逆转录病毒药物依从性:治疗可及的第一年
Am J Trop Med Hyg. 2009 Apr;80(4):669-74.
4
Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa.在南非接受抗逆转录病毒治疗项目的患者中进行隐球菌抗原血症筛查。
Clin Infect Dis. 2009 Apr 1;48(7):856-62. doi: 10.1086/597262.
5
The International HIV Dementia Scale is a useful screening tool for HIV-associated dementia/cognitive impairment in HIV-infected adults in Yaoundé-Cameroon.国际HIV痴呆量表是喀麦隆雅温得地区HIV感染成人中HIV相关痴呆/认知障碍的一种有用筛查工具。
J Acquir Immune Defic Syndr. 2008 Dec 1;49(4):393-7. doi: 10.1097/qai.0b013e318183a9df.
6
Validity/reliability of PHQ-9 and PHQ-2 depression scales among adults living with HIV/AIDS in western Kenya.肯尼亚西部感染艾滋病毒/艾滋病的成年人中PHQ-9和PHQ-2抑郁量表的效度/信度
J Gen Intern Med. 2009 Feb;24(2):189-97. doi: 10.1007/s11606-008-0846-z. Epub 2008 Nov 20.
7
Cognitive functioning in a population-based sample of young adults with a history of non-psychotic unipolar depressive disorders without psychiatric comorbidity.在一个基于人群的、无精神疾病共病的非精神病性单相抑郁症病史的年轻成年人样本中的认知功能。
J Affect Disord. 2008 Sep;110(1-2):36-45. doi: 10.1016/j.jad.2007.12.239. Epub 2008 Feb 14.
8
Updated research nosology for HIV-associated neurocognitive disorders.人类免疫缺陷病毒相关神经认知障碍的更新研究分类学
Neurology. 2007 Oct 30;69(18):1789-99. doi: 10.1212/01.WNL.0000287431.88658.8b. Epub 2007 Oct 3.
9
Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy.高效抗逆转录病毒治疗时代人类免疫缺陷病毒相关痴呆的发病率及预测因素变化
Ann Neurol. 2008 Feb;63(2):213-21. doi: 10.1002/ana.21225.
10
Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda.乌干达农村地区抗逆转录病毒治疗期间无症状血清隐球菌抗原血症与早期死亡率
Trop Med Int Health. 2007 Aug;12(8):929-35. doi: 10.1111/j.1365-3156.2007.01874.x.